Clinical Trial Update: Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing perioperative chemotherapy plus cetuximab versus chemotherapy alone for high-risk resectable colorectal liver metastasis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastasis

Drugs mentioned

• Cetuximab (cetuximab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Colorectal Cancer Stage IV, Metastasis | Phase 2, Phase 3 | Status: COMPLETED